EGRX Eagle Pharmaceuticals, Inc. Stock Quote

EGRX [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	43.70	EPS (ttm)	1.06	Insider Own	12.60%	Shs Outstand	13.07M	Perf Week	-3.38%
Market Cap	611.54M	Forward P/E	11.20	EPS next Y	4.16	Insider Trans	0.00%	Shs Float	11.48M	Perf Month	3.03%
Income	14.40M	PEG	16.19	EPS next Q	0.80	Inst Own	96.80%	Short Float	8.06%	Perf Quarter	14.57%
Sales	183.00M	P/S	3.34	EPS this Y	-14.00%	Inst Trans	1.02%	Short Ratio	8.10	Perf Half Y	0.11%
Book/sh	14.62	P/B	3.18	EPS next Y	31.97%	ROA	5.70%	Target Price	47.33	Perf Year	-3.28%
Cash/sh	8.01	P/C	5.81	EPS next 5Y	2.70%	ROE	7.90%	52W Range	36.48 - 53.43	Perf YTD	-0.06%
Dividend	-	P/FCF	10.90	EPS past 5Y	40.60%	ROI	10.20%	52W High	-12.90%	Beta	0.74
Dividend %	-	Quick Ratio	3.70	Sales past 5Y	23.20%	Gross Margin	73.50%	52W Low	27.58%	ATR	1.52
Employees	106	Current Ratio	3.90	Sales Q/Q	-10.40%	Oper. Margin	13.70%	RSI (14)	51.41	Volatility	3.14% 3.50%
Optionable	Yes	Debt/Eq	0.16	EPS Q/Q	84.70%	Profit Margin	7.90%	Rel Volume	0.61	Prev Close	47.95
Shortable	Yes	LT Debt/Eq	0.12	Earnings	Aug 09 BMO	Payout	0.00%	Avg Volume	114.36K	Price	46.54
Recom	2.20	SMA20	-1.51%	SMA50	6.69%	SMA200	3.25%	Volume	69,832	Change	-2.94%

Apr-07-21

Resumed

RBC Capital Mkts

Outperform

$52

Nov-01-18

Downgrade

Cantor Fitzgerald

Overweight → Neutral

Oct-31-18

Downgrade

Piper Jaffray

Overweight → Neutral

Mar-21-18

Reiterated

Mizuho

Underperform

$37 → $40

Nov-09-17

Reiterated

RBC Capital Mkts

Outperform

$81 → $75

Sep-06-17

Reiterated

Mizuho

Underperform

$40 → $37

Jul-27-17

Reiterated

RBC Capital Mkts

Outperform

$94 → $81

Jul-27-17

Reiterated

Mizuho

Underperform

$57 → $40

May-09-17

Reiterated

RBC Capital Mkts

Outperform

$86 → $94

Jan-09-17

Downgrade

Mizuho

Neutral → Underperform

$78 → $64

Nov-16-16

Downgrade

Mizuho

Buy → Neutral

$78

Nov-03-16

Upgrade

Mizuho

Neutral → Buy

$62 → $78

Nov-03-16

Reiterated

RBC Capital Mkts

Outperform

$80 → $93

Oct-26-16

Reiterated

Mizuho

Buy

$65 → $62

Aug-16-16

Reiterated

Mizuho

Neutral

$47 → $65

Jun-20-16

Downgrade

Mizuho

Buy → Neutral

$66 → $47

May-10-16

Reiterated

RBC Capital Mkts

Outperform

$94 → $78

Mar-18-16

Reiterated

Mizuho

Buy

$81 → $71

Feb-26-16

Reiterated

Mizuho

Buy

$112 → $81

Dec-09-15

Initiated

Mizuho

Buy

$112

Aug-02-21 03:01PM	Eagle Pharmaceuticals (EGRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Jul-29-21 03:32PM	Were Hedge Funds Right About Eagle Pharmaceuticals Inc (EGRX)? Insider Monkey
Jul-28-21 04:30PM	Eagle Pharmaceuticals to Host Second Quarter 2021 Financial Results on August 9, 2021 Business Wire
Jul-14-21 02:28AM	Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? Simply Wall St.
Jun-24-21 06:50AM	Eagle Pharmaceuticals Announces FDA Maintains Prioritization of ANDA for Vasopressin Business Wire
Jun-18-21 10:47AM	New Strong Sell Stocks for June 18th Zacks
Jun-17-21 06:50AM	Eagle Pharmaceuticals Submits Response to Complete Response Letter from FDA for Vasopressin Business Wire
Jun-11-21 12:08PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Eagle Pharmaceuticals, Inc.- EGRX Newsfile
May-30-21 04:06AM	Would Shareholders Who Purchased Eagle Pharmaceuticals' (NASDAQ:EGRX) Stock Three Years Be Happy With The Share price Today? Simply Wall St.
May-26-21 05:00PM	Eagle Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021 Business Wire
May-14-21 05:54PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Eagle Pharmaceuticals, Inc.- EGRX Newsfile
May-11-21 05:00PM	Eagle Pharmaceuticals to Present at the 2021 RBC Capital Markets Global Healthcare Conference Business Wire
May-10-21 11:30AM	Eagle Pharmaceuticals Inc (EGRX) Q1 2021 Earnings Call Transcript Motley Fool -7.64%
08:05AM	Eagle Pharmaceuticals (EGRX) Q1 Earnings and Revenues Miss Estimates Zacks
06:50AM	Eagle Pharmaceuticals Reports First Quarter 2021 Results Business Wire
06:45AM	Eagle Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
06:45AM	Eagle Pharmaceuticals Announces Filing of TREAKISYM (bendamustine) Rapid Infusion ("RI") Liquid Formulation in Japan Business Wire
May-03-21 03:01PM	Analysts Estimate Eagle Pharmaceuticals (EGRX) to Report a Decline in Earnings: What to Look Out for Zacks
06:50AM	Eagle Pharmaceuticals Appoints Former FDA Official and Public Health Expert Dr. Luciana Borio to its Board of Directors Business Wire
Apr-30-21 06:50AM	Eagle Pharmaceuticals Announces TREAKISYM (bendamustine) Ready-to-Dilute ("RTD") Formulation, in Combination with Rituximab for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma Receives PMDA Approval in Japan Business Wire
Apr-29-21 04:30PM	Eagle Pharmaceuticals to Host First Quarter 2021 Financial Results on May 10, 2021 Business Wire
07:05AM	TEVA Beats on Q1 Earnings and Sales, Keeps View, Stock Down Zacks
Apr-22-21 12:28PM	Heres Why Summers Value Partners Exited its Eagle Pharmaceuticals (EGRX) Position Insider Monkey
Apr-15-21 03:22AM	We Think Eagle Pharmaceuticals (NASDAQ:EGRX) Can Manage Its Debt With Ease Simply Wall St.
Mar-15-21 04:08PM	Top Pharmaceutical Stocks for Q2 2021 Investopedia
Mar-03-21 12:23AM	Is Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Trading At A 21% Discount? Simply Wall St.
Mar-02-21 02:00PM	Eagle Pharmaceuticals Inc (EGRX) Q4 2020 Earnings Call Transcript Motley Fool -10.97%
08:15AM	Eagle Pharmaceuticals (EGRX) Beats Q4 Earnings Estimates Zacks
06:50AM	Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results and Provides Pipeline Review Business Wire
06:30AM	Eagle Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-01-21 10:15AM	Earnings Preview: Eagle Pharmaceuticals Benzinga
Feb-22-21 04:30PM	Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Financial Results and Pipeline Review on March 2, 2021 Business Wire
Feb-02-21 07:45AM	FDA Rejects Eagle Pharma's Vasopressin Application Benzinga
06:50AM	Eagle Pharmaceuticals Receives Additional FDA Questions Regarding Vasopressin; Court Date Set for July 7, 2021 in Vasopressin Trial Business Wire
Feb-01-21 06:50AM	Eagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date Postponed Business Wire
Jan-11-21 06:50AM	Eagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date Postponed from January 11, 2021 to February 1, 2021 to Protect Against COVID-19 Concerns Business Wire
Jan-04-21 04:30PM	Eagle Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference Business Wire
Jan-03-21 02:45AM	Eagle Pharmaceuticals, Inc.'s (NASDAQ:EGRX) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? Simply Wall St.
Dec-15-20 07:27PM	Is EGRX A Good Stock To Buy Now? Insider Monkey
Nov-23-20 06:50AM	Eagle Pharmaceuticals Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing Business Wire
Nov-04-20 06:10AM	Eagle Pharmaceuticals, Inc. Just Beat EPS By 2,450%: Here's What Analysts Think Will Happen Next Simply Wall St.
Nov-02-20 12:30PM	Eagle Pharmaceuticals Inc (EGRX) Q3 2020 Earnings Call Transcript Motley Fool +5.80%
08:24AM	Eagle Pharmaceuticals: Q3 Earnings Insights Benzinga
08:05AM	Eagle Pharmaceuticals (EGRX) Beats Q3 Earnings and Revenue Estimates Zacks
06:47AM	Eagle Pharmaceuticals Reports Third Quarter 2020 Results Business Wire
06:45AM	Eagle Pharmaceuticals Strengthens Management Team to Prepare for Future Growth Business Wire
Oct-26-20 04:30PM	Eagle Pharmaceuticals to Discuss Third Quarter 2020 Financial Results on November 2, 2020 Business Wire
Oct-15-20 09:20AM	New Strong Sell Stocks for October 15th Zacks
08:19AM	Reflecting on Eagle Pharmaceuticals' (NASDAQ:EGRX) Share Price Returns Over The Last Year Simply Wall St.
Sep-25-20 02:13PM	Eagle Pharmaceuticals (EGRX) Has Fallen 26% in Last One Year, Underperforms Market Insider Monkey
Sep-24-20 11:30AM	Companies Are Starting to Buy Back Stock Again. Why Thats Good News. CoinDesk
11:30AM	Companies Are Starting to Buy Back Stock Again. Why Thats Good News. Barrons.com
06:50AM	Eagle Pharmaceuticals Commences $25 Million Accelerated Share Repurchase as Part of Existing $160 Million Share Repurchase Program Business Wire
Sep-23-20 06:50AM	Eagle Pharmaceuticals Japanese Licensing Partner, SymBio, Receives Approval of TREAKISYM Ready-To-Dilute ("RTD") Formulation, with Launch Expected in January 2021 Business Wire
Sep-09-20 11:07AM	Eagle Pharmaceuticals (EGRX) Has Fallen 38% in Last One Year, Underperforms Market Insider Monkey
Sep-08-20 06:50AM	Eagle Pharmaceuticals to Present at Upcoming September 2020 Healthcare Conferences Business Wire
Aug-19-20 06:50AM	Eagle Pharmaceuticals Announces Publication of Preclinical Study of Intranasal Dantrolene in Journal of Alzheimers Disease Business Wire
Aug-10-20 01:30PM	Eagle Pharmaceuticals Inc (EGRX) Q2 2020 Earnings Call Transcript Motley Fool -7.96%
08:15AM	Eagle Pharmaceuticals (EGRX) Q2 Earnings and Revenues Top Estimates Zacks
07:06AM	Recap: Eagle Pharmaceuticals Q2 Earnings Benzinga
06:50AM	Eagle Pharmaceuticals Reports Second Quarter 2020 Results Business Wire
Aug-03-20 04:30PM	Eagle Pharmaceuticals to Discuss Second Quarter 2020 Financial Results on August 10, 2020 Business Wire
Jul-31-20 03:56PM	Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates Benzinga
Jul-17-20 11:47AM	Is Eagle Pharmaceuticals, Inc.'s (NASDAQ:EGRX) Recent Stock Performance Influenced By Its Fundamentals In Any Way? Simply Wall St.
Jul-09-20 12:00PM	CMS Establishes Unique J-Code for Eagle Pharmaceuticals PEMFEXY (Pemetrexed for Injection) Business Wire
Jun-27-20 09:28PM	Hedge Funds Are Buying Eagle Pharmaceuticals Inc (EGRX) Insider Monkey
Jun-10-20 04:08PM	Edited Transcript of EGRX earnings conference call or presentation 11-May-20 12:30pm GMT Thomson Reuters StreetEvents
May-26-20 04:30PM	Eagle Pharmaceuticals to Present at June Investor Conferences Business Wire
May-22-20 04:05PM	Eagle Pharmaceuticals Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders Business Wire
May-14-20 11:50AM	Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Analysts Just Slashed This Year's Estimates Simply Wall St.
May-12-20 04:30PM	Eagle Pharmaceuticals to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference Business Wire
May-11-20 12:30PM	Eagle Pharmaceuticals Inc (EGRX) Q1 2020 Earnings Call Transcript Motley Fool
08:35AM	Eagle Pharmaceuticals (EGRX) Q1 Earnings Surpass Estimates Zacks
08:14AM	Eagle Pharmaceuticals: Q1 Earnings Insights Benzinga
07:22AM	A Look At The Fair Value Of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Simply Wall St.
06:50AM	Eagle Pharmaceuticals Reports First Quarter 2020 Results Business Wire
May-08-20 08:41AM	Why Eagle Pharmaceuticals (EGRX) Might Surprise This Earnings Season Zacks
May-07-20 06:07AM	3 Medical Product Stocks Set to Beat This Earnings Season Zacks
May-04-20 06:50AM	Eagle Pharmaceuticals Advances Novel and Proprietary Formulation of Fulvestrant Product Candidate EA-114; Company to Request Additional Meeting with U.S. Food and Drug Administration ("FDA") Business Wire
Apr-29-20 04:30PM	Eagle Pharmaceuticals to Discuss First Quarter 2020 Financial Results on May 11, 2020 Business Wire
Apr-28-20 12:33PM	Earnings Preview: Eagle Pharmaceuticals (EGRX) Q1 Earnings Expected to Decline Zacks
06:50AM	Court Issues Favorable Patent Litigation Decision for Eagle Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd. for BENDEKA (bendamustine hydrochloride injection) Business Wire
Apr-16-20 05:24PM	Covid Report: Gilead Pops On Promising Sneak Peek For Coronavirus Drug Investor's Business Daily +7.14%
06:50AM	Eagle Pharmaceuticals Announces Laboratory Test Results Demonstrating In Vitro Antiviral Activity of RYANODEX® (dantrolene sodium) Against Coronavirus SARS-CoV-2 Business Wire
Apr-11-20 09:25AM	What Is Eagle Pharmaceuticals's (NASDAQ:EGRX) P/E Ratio After Its Share Price Rocketed? Simply Wall St.
Mar-30-20 06:50AM	Eagle Pharmaceuticals Japanese Licensing Partner SymBio Announces Completion of Clinical Trial Enrollment for TREAKISYM® Rapid Infusion Liquid Bendamustine Formulation Business Wire +12.91%
Mar-24-20 02:20AM	Edited Transcript of EGRX earnings conference call or presentation 2-Mar-20 1:30pm GMT Thomson Reuters StreetEvents +5.87%
Mar-10-20 07:55AM	What Is Eagle Pharmaceuticals's (NASDAQ:EGRX) P/E Ratio After Its Share Price Tanked? Simply Wall St. +5.69%
Mar-02-20 08:15AM	Eagle Pharmaceuticals (EGRX) Surpasses Q4 Earnings and Revenue Estimates Zacks -8.80%
06:50AM	Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Results Business Wire
Feb-24-20 12:30PM	Earnings Preview: Eagle Pharmaceuticals (EGRX) Q4 Earnings Expected to Decline Zacks
Feb-19-20 04:30PM	Eagle Pharmaceuticals to Discuss Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020 Business Wire
Feb-13-20 07:50AM	Eagle Pharmaceuticals (NASDAQ:EGRX) Has A Pretty Healthy Balance Sheet Simply Wall St.
Feb-10-20 09:54AM	Eagle Pharmaceuticals Receives Final FDA Approval for PEMFEXY (Pemetrexed for Injection) Business Wire
Jan-13-20 06:50AM	Eagle Pharmaceuticals to Develop Dantrolene Sodium for Potential Treatment of Alzheimers Disease in Collaboration With University of Pennsylvania Business Wire
Jan-09-20 08:40AM	Tyme Initiates Dosing in Pivotal Pancreatic Cancer Study Zacks
06:50AM	Eagle Pharmaceuticals Resubmits NDA for RYANODEX for Exertional Heat Stroke Business Wire
Jan-08-20 10:18AM	Tyme Out-Licenses Cancer Candidate to Eagle Pharma, Stock Up Zacks
08:16AM	Is Eagle Pharmaceuticals, Inc.'s (NASDAQ:EGRX) ROE Of 15% Concerning? Simply Wall St.
Jan-07-20 09:25AM	Tyme stock rises on Eage collaboration for cancer drug MarketWatch

Eagle Pharmaceuticals, Inc., a biotechnology pharmaceutical company, focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also includes EP-4104, a dantrolene sodium for exertional heat stroke, as well as to treat organophosphate exposure; EP-5101 (PEMFEXY) for lung cancer and mesothelioma; EGL-5385-C-1701 (fulvestrant) for breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has a strategic collaboration with Tyme Technologies, Inc. to advance oral SM-88 for the treatment of patients with cancer. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RATOFF STEVEN B	Director	Apr 08	Option Exercise	7.33	7,020	51,433	27,364	Apr 12 04:38 PM
Tarriff Scott	CEO	Apr 01	Option Exercise	8.78	31,201	273,945	1,561,184	Apr 05 04:54 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience